bioRN annual report 2024

bioRN annual report 2024

New Member: Welcome in our cluster to Myotwin GmbH

At Myotwin, the vision is to revolutionize drug development through innovation and compassion. The team is creating a digital twin of the human heart muscle, built from extensive high-content datasets, to enable animal-free drug testing. This groundbreaking platform aims to reshape pharmaceutical research by offering ethical, precise, and effective drug testing methods. By leveraging technology […]

New Member: Welcome in our cluster to Cell Signaling Technology Europe B.V.

Cell Signaling Technology (CST) is a private, family-owned company, founded by scientists and dedicated to providing high-quality research tools to the biomedical research community. CST empowers scientists worldwide with innovative, high-quality tools to advance discovery. Beyond science, CST prioritizes responsibility by partnering with communities and minimizing environmental impact. As the first life science member of […]